Man Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.9M Buy
75,983
+40,397
+114% +$21.2M 0.08% 265
2025
Q1
$22.6M Sell
35,586
-558
-2% -$354K 0.06% 345
2024
Q4
$25.7M Sell
36,144
-24,377
-40% -$17.4M 0.07% 296
2024
Q3
$63.6M Buy
60,521
+8,777
+17% +$9.23M 0.17% 143
2024
Q2
$54.4M Sell
51,744
-56,728
-52% -$59.6M 0.14% 157
2024
Q1
$104M Buy
108,472
+14,912
+16% +$14.4M 0.26% 74
2023
Q4
$82.2M Buy
+93,560
New +$82.2M 0.23% 93
2023
Q3
Sell
-116,636
Closed -$83.8M 225
2023
Q2
$83.8M Buy
+116,636
New +$83.8M 0.26% 80
2023
Q1
Sell
-77,120
Closed -$55.6M 281
2022
Q4
$55.6M Buy
77,120
+57,473
+293% +$41.5M 0.2% 113
2022
Q3
$13.5M Buy
+19,647
New +$13.5M 0.06% 374
2022
Q2
Sell
-29,970
Closed -$20.9M 254
2022
Q1
$20.9M Sell
29,970
-117,219
-80% -$81.9M 0.07% 301
2021
Q4
$93M Buy
147,189
+66,819
+83% +$42.2M 0.3% 62
2021
Q3
$48.6M Sell
80,370
-28,583
-26% -$17.3M 0.17% 128
2021
Q2
$60.9M Sell
108,953
-11,314
-9% -$6.32M 0.21% 97
2021
Q1
$56.9M Buy
120,267
+74,920
+165% +$35.4M 0.25% 87
2020
Q4
$21.9M Buy
45,347
+17,041
+60% +$8.23M 0.1% 203
2020
Q3
$15.8M Sell
28,306
-5,658
-17% -$3.17M 0.06% 327
2020
Q2
$21.2M Buy
33,964
+3,280
+11% +$2.05M 0.11% 184
2020
Q1
$15M Buy
30,684
+2,363
+8% +$1.15M 0.1% 214
2019
Q4
$10.6M Buy
28,321
+13,695
+94% +$5.14M 0.04% 664
2019
Q3
$4.06M Sell
14,626
-2,383
-14% -$661K 0.02% 961
2019
Q2
$5.33M Buy
17,009
+12,980
+322% +$4.06M 0.02% 918
2019
Q1
$1.65M Sell
4,029
-1,647
-29% -$676K 0.01% 1397
2018
Q4
$2.12M Sell
5,676
-490
-8% -$183K 0.01% 1189
2018
Q3
$2.49M Sell
6,166
-74
-1% -$29.9K 0.01% 1312
2018
Q2
$2.15M Sell
6,240
-41
-0.7% -$14.1K 0.01% 1321
2018
Q1
$2.16M Buy
+6,281
New +$2.16M 0.01% 1233